Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • New RAIN RFID Loop Tag for Jewelers From SimplyRFiD Raises the Standard for Inventory
    New RAIN RFID Loop Tag for Jewelers From SimplyRFiD Raises the Standard for Inventory Business
  • On the Brand that trademarked Xmas
    On the Brand that trademarked Xmas Business
  • Vietnam Emerges as Competitive Manufacturing Hub, Challenging China’s Dominance in Uniform Production
    Vietnam Emerges as Competitive Manufacturing Hub, Challenging China’s Dominance in Uniform Production Business
  • Bringing Trusted Nanny Services to Local Families
    Bringing Trusted Nanny Services to Local Families World News
  • Clinton Makes RFK Assassination Remark
    Clinton Makes RFK Assassination Remark World News
  • Nuclear-Fusion Breakthrough: How Long Until Limitless Clean Energy? | Tech News Briefing | WSJ
    Nuclear-Fusion Breakthrough: How Long Until Limitless Clean Energy? | Tech News Briefing | WSJ World News
  • Secretary Blinken’s Meeting with Indonesian Foreign Minister Marsudi
    Secretary Blinken’s Meeting with Indonesian Foreign Minister Marsudi World News
  • Global Growth Comments on Liquidation of Greg Lindberg’s North Carolina Insurers
    Global Growth Comments on Liquidation of Greg Lindberg’s North Carolina Insurers World News
Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Posted on November 15, 2024 By NewsEditor

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular Inc

Solaris SX is very flexible

Solaris SX Flexibility

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /EINPresswire.com/ — Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery Disease (PAD). Solaris Endovascular develops evidence-based technologies, intended to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries to allow patients to lead healthier lives with fewer interventions.

End-Stage Kidney Disease (ESKD) is a major health concern affecting approximately 10 million people worldwide with approximately 3 million people receiving kidney replacement therapy and relying on hemodialysis to survive. Over 50% of these patients experience vascular access failures within the first year and are subjected to hospital admissions and repeated costly endovascular or surgical interventions to restore their lifeline to dialysis—this drastically impacts quality of life, treatment effectiveness and survival.

In April 2024, the American Heart Association reported that the global prevalence of peripheral artery disease (PAD) may be as high as 230 million people. PAD can progress from painful walking to critical limb ischemia, and many patients require revascularization procedures to restore blood flow, improve symptoms, or prevent amputations.

Stent-grafts are emerging as the preferred minimally invasive treatment for these conditions and Solaris Endovascular is currently selling the latest generation of stent-grafts. The flagship Solaris(TM) SX Vascular Stent Graft employs the most advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. This thin, multi-directional PTFE membrane encapsulates a nitinol stent that provides flexibility, high radial strength, and crush resistance for optimal blood flow. These features are already proven in global markets with more than 13,000 units sold to date. Interventional and endovascular physicians worldwide have chosen Solaris SX for its trackability and precise pinpoint deployment, ensuring accurate placement.

“Bringing this innovative technology to the United States is a major step forward in improving the lives of patients,” said Dr. Marco Costa, Chairman and Chief Medical & Scientific Officer at Solaris Endovascular Inc. “Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet need in covered stents: edge stenosis. Solaris DE incorporates Sirolimus, a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination of restenosis, from 30% to 3%.

“We expect Solaris DE to deliver similar transformative results to patients with ESKD and PAD,” said Dr. Costa.

CEO Randy Hubbell emphasized the company’s unique position in the market: “Solaris Endovascular represents a rare opportunity to start a new company that is revenue producing from the beginning, has a decade-plus manufacturing expertise in stents, stent grafts and endovascular drug delivery, and a proven product supported by clinical studies in multiple markets before entering the U.S. Our platform addresses a significant unmet need in both dialysis access and PAD, offering life-changing solutions for patients while setting a new standard in endovascular care.”

As Solaris Endovascular prepares for the U.S. registration process, it is committed to driving meaningful improvements in patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs.

About Solaris Endovascular, Inc.

Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.

For more information, please visit: [www.solarisendovascular.com]

Randy Hubbell
Solaris Endovascular, Inc.
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 13, 2024, 13:30 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Beauty & Hair Care, Business & Economy, Chemical Industry, Companies, Conferences & Trade Fairs, Culture, Society & Lifestyle, Education, Emergency Services …


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Business

Post navigation

Previous Post: Maria Cecilia Conder selected as Top Board Member of the Year in Fine Arts by IAOTP
Next Post: Tech and Social Impact Leaders Converge at Goodera’s AI for Impact Summit

Related Posts

  • Korean Startup WeBudding Partners Exclusively With the Most Popular Free App Goodnotes 5 to Provide Korean Digital Stationery Content to Users Globally
    Korean Startup WeBudding Partners Exclusively With the Most Popular Free App Goodnotes 5 to Provide Korean Digital Stationery Content to Users Globally Business
  • MCMANN CAPITAL UNVEILS REVOLUTIONARY BUSINESS-PERSONAL LINE OF CREDIT (PLOC) OFFERING UNPARALLELED FLEXIBILITY/BENEFITS
    MCMANN CAPITAL UNVEILS REVOLUTIONARY BUSINESS-PERSONAL LINE OF CREDIT (PLOC) OFFERING UNPARALLELED FLEXIBILITY/BENEFITS Business
  • New Report From Richard Florida Aims to Define, Size and Propel the Creator Economy
    New Report From Richard Florida Aims to Define, Size and Propel the Creator Economy Business
  • 22.3% of the Surveyed Respondents are Ready to Take Moderate Risks while Making Investment Decisions
    22.3% of the Surveyed Respondents are Ready to Take Moderate Risks while Making Investment Decisions Business
  • BRIXY Launches Nationwide Retail Partnership With Sprouts Farmers Market
    BRIXY Launches Nationwide Retail Partnership With Sprouts Farmers Market Business
  • atkrypto.io commences “atkrypto for SAP” TestNet Public Blockchain on SAP Business Technology Platform BTP Kyma trial
    atkrypto.io commences “atkrypto for SAP” TestNet Public Blockchain on SAP Business Technology Platform BTP Kyma trial Business
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Dr. Mohana Rao presented at SNVICON 2025 for Groundbreaking Treatment of Giant Brain AneurysmJuly 1, 2025
  • Maxiforce Expands Operations into England, Delivering Reliable Diesel Engine Parts Across UKJuly 1, 2025
  • Carla Marcos Hypnotherapy Recognized as Top Hypnotherapy Program of the Year by IAOTBJuly 1, 2025
  • A U.S. Long-Term Residency Pathway for Skilled Pilots and Their FamiliesJune 30, 2025
  • RISE Exhibits & Environments Empowers Companies with Custom Tradeshow Booth DesignJune 30, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Hospital-acquired ICU Bloodstream Infections: Higher Risk of Death
    Hospital-acquired ICU Bloodstream Infections: Higher Risk of Death Business
  • IF YOUR FINANCIAL ADVISOR RECOMMENDED CROCS, INC. INVESTMENTS PLEASE CONTACT KT LAW
    IF YOUR FINANCIAL ADVISOR RECOMMENDED CROCS, INC. INVESTMENTS PLEASE CONTACT KT LAW Business
  • Jason Mitchell Group Celebrates Record Month in Arizona Real Estate
    Jason Mitchell Group Celebrates Record Month in Arizona Real Estate Business
  • Thrive International Acquires Capelle Miami, Expanding Portfolio Into Premium Men’s Lifestyle Market
    Thrive International Acquires Capelle Miami, Expanding Portfolio Into Premium Men’s Lifestyle Market Business
  • Assistant Secretary Pyatt’s Travel to Houston
    Assistant Secretary Pyatt’s Travel to Houston World News
  • NONPROFIT POLITISIT PARTNERS WITH TOP CARE ORGANIZATIONS TO PROVIDE FREE CHILDCARE ON ELECTION DAY
    NONPROFIT POLITISIT PARTNERS WITH TOP CARE ORGANIZATIONS TO PROVIDE FREE CHILDCARE ON ELECTION DAY Business
  • Golovanov #29: Replay of Scenario. The Only Way for West to Win (pt2).
    Golovanov #29: Replay of Scenario. The Only Way for West to Win (pt2). World News
  • Global Computer Hardware Market Growth Trajectory
    Global Computer Hardware Market Growth Trajectory World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .